ABLE Exo provides physiological gait
First lightweight, easy-to-use and affordable exoskeleton that restores the ability to walk of people with lower-limb paralysis.
ABLE exoskeleton, Rehabilitation, Human walking, Walk again, Lower-limb paralysis, Spinal cord injury, Stroke, Neurorehabilitation, Affordable exoskeleton, Lightweight exoskeleton, Easy to use exoskeleton, Healthcare robotics, Assistive technology, Medical device, Medtech, Barcelona, Innovation, Technology, Biomechatronics
34330
post-template-default,single,single-post,postid-34330,single-format-standard,bridge-core-1.0.6,ajax_updown,page_not_loaded,,qode-title-hidden,qode_grid_1400,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-theme-ver-18.2,qode-theme-bridge,qode_advanced_footer_responsive_1000,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

30 Dec ABLE Exo provides physiological gait

Posted at 11:16h in Media by

Recovering the ability to stand and walk independently can have numerous health benefits for people with spinal cord injury (SCI).

 

Exoskeletons are seen as a promising alternative to traditional knee-ankle-foot orthoses (KAFOs) for gait training and assisting functional mobility in people with SCI. However, comparisons between these two types of devices in terms of gait biomechanics and energetics have been limited. Our research study compared the ABLE Exoskeleton with KAFOs in a randomized, crossover clinical trial at ASEPEYO Hospital Barcelona with 10 SCI patients that completed a 10-session gait training program with each device followed by user satisfaction questionnaires. 

 

Walking with the ABLE Exoskeleton improved gait kinematics compared to the KAFOs, providing a more physiological gait pattern with less compensatory movements (38% reduction of circumduction, 25% increase of step length, 29% improvement in weight shifting).

 

Participants were also more satisfied with the ABLE device. However, improvements in gait kinematics did not extend to significant improvements in energy efficiency.

These results suggest that providing powered assistance only on the knee joints is not enough to significantly reduce the energy consumption required by people with SCI to walk compared to passive orthoses. Active assistance on the hip or ankle joints seems necessary to achieve this outcome. The findings of this clinical trial were key to improve the ABLE Exoskeleton and develop its final version that includes active assistance on the hip.

 

Read the publication here: https://www.nature.com/articles/s41598-022-23556-4



×

Request a demo in your clinic

 

× Request a demo in your clinic